Prebiotic oligosaccharides

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The The Regents Of The University Of California, , Dsm Food Specialties Usa Inc. patent solves the following problem:

Galacto-oligosaccharides (gos) the non-digestible carbohydrates and versatile food mixture to possess prebiotic properties (Angus, F., Smart, S. and Shortt, C. 2005. Probiotic Dairy Products ed. Tamine A. pp. 120 137. Oxford: Blackwell Publishing). Moreover, many other health benefits report for these oligosaccharides including: development of defecation, stimulation of mineral absorption, elimination of ammonium, prevention colon cancer, as well as to protect against certain pathogenic bacteria infection (Hopkins, MJ and Macfarlane, GT 2003 around Appl Microbiol 69, 1920-1927; Shoaf, K., GL Mulvey, GD Armstrong and RW Hutkins 2006 infect Immun 74 :. 6920-8; Macfarlane, GT, horse H. Macfarlane S. 2008 Journal of Applied Microbiology 104, 305-44).

Our analysis of this patent is as follows:

The Regents Of The University Of California, , Dsm Food Specialties Usa Inc.’s patent US 8425930 B2 deals with Prebiotic oligosaccharides.
The present invention provides galacto-oligosaccharide composition that preferentially stimulate the growth of certain strains of Bifidobacterium species.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Determining the capability of a test compound to affect solid tumor stem cells

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The The Regents Of The University Of Michigan, , Oncomed Pharmaceuticals, Inc. patent solves the following problem:

Cancer remains the number two cause of death in this country, resulting in more than 500,000 deaths each year. Despite progress in detection and treatment, cancer mortality remains high. Despite remarkable progress in understanding the molecular basis of cancer, this knowledge has not yet translated into effective therapeutic strategies.

Our analysis of this patent is as follows:

The Regents Of The University Of Michigan, , Oncomed Pharmaceuticals, Inc.’s patent US 8420885 B2 deals with Determining the capability of a test compound to affect solid tumor stem cells.
A small percentage of cells in a firm with strong tumor properties of stem cells. These strong tumor stem cells give rise to two more tumor stem cells and the majority of tumor cells that have lost the capacity for growth and the ability to give rise to new tumors. Therefore, strong tumor heterogeneity appeared before the tumor cell line arising from a strong tumor stem cells. A xenograft model in which we can build in tumors from primary tumors by injection of tumor cells in mammary England severely immunodeficient mice. These xenograft assay allows us to do the biological and molecular assays virtue clonogenic strong tumor stem cells. We also found evidence that strongly implicates the notch road, especially to notch 4, as playing a central pathway of carcinogenesis.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Apparatus for reducing drag on a vehicle

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Lonnie Litchfield patent solves the following problem:

The present invention relates to a drag reduction device attachable to a rear portion of a vehicle to reduce drag on the car. Furthermore, the present invention is directed to a method of producing and implementing drag reduction devices.

Our analysis of this patent is as follows:

Lonnie Litchfield’s patent US 8414064 B2 deals with Apparatus for reducing drag on a vehicle.
The present invention is directed to a device for reducing the drag of a car. The device consists of a sheet of material and a plurality of depressions / elevations. The sheet material having a base portion and an apex extending from the base portion.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

High energy liquid enteral nutritional composition

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The N. V. Nutricia patent solves the following problem:

The present invention relates in general to a liquid enteral composition for providing nutrition, or as a supplement, or as a complete nutrition, with a high energy inside.

Our analysis of this patent is as follows:

N. V. Nutricia’s patent US 8409651 B2 deals with High energy liquid enteral nutritional composition.
High energy and high protein liquid nutrition enteral composition which includes micellar casein and caseinate, a optionally a small amount of whey.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Impact-resistant composition based on a polyamide resin and on a blend of at least one graft copolymer with polyamide blocks and a low-density ethylene polymer

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Arkema France patent solves the following problem:

The improvement in impact strength of polyamides are usually obtained by integrating, in the form of a dispersed phase, an impact modifier which is elastomeric in nature and have reactive functional groups (acrylic acid, maleic anhydride, etc.) can react with the functional groups, such as NH2 chain end, the polyamide matrix. reactivity This makes it possible to ensure a fine homogeneous dispersion of the elastomer by controlling the size of the particles or nodules, a good adhesion to the nodule / matrix interface, and obtain a highest increase in impact strength. However, the drawback of this approach is the thickening of the blend, because the modifier coupling PA-effects, which leads to a significant fall in the melt flow. This great change in viscosity disrupt the processing of the composition, especially for thin or large-sized injection-molded parts, and extrusion.

Our analysis of this patent is as follows:

Arkema France’s patent US 8410216 B2 deals with Impact-resistant composition based on a polyamide resin and on a blend of at least one graft copolymer with polyamide blocks and a low-density ethylene polymer.
The invention relates to a composition based on an impact-resistant thermoplastic polyamide resin, which contains, as a blendfrom 60 to 98 wt% of polyamide resin (A) andfrom 2 to 40 wt% of a combination of at least one graft copolymer with polyamide blocks (B) comprising a polyolefin backbone and at least one polyamide graft in which the grafts attached to the backbone by the residues of an unsaturated monomer (X) having a functional group able to react in a wet-terminated polyamide, the residues of the unsaturated monomer (X) attached to the backbone by grafting or copolymerization via its double bond, and a non -sumbalik ethylenic polymer (C) is miscible in (B) and has a density below 0.960 g / cm3.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.